SMTL ID : 6fph.1 (1 other biounit)

The crystal structure of P.fluorescens Kynurenine 3-monooxygenase (KMO) in complex with competitive inhibitor No. 1h

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)

FAD.1: 39 residues within 4Å: Chain A: I.12, G.13, A.14, G.15, L.16, A.17, G.18, F.35, E.36, R.37, R.38, L.54, A.55, R.110, L.132, G.133, L.134, A.164, D.165, G.166, A.170, Y.192, E.194, L.225, T.235, F.237, L.291, G.309, D.310, A.311, P.317, G.320, Q.321, G.322, M.323, N.324, A.326 Ligands: CL.2, E1W.3 35 PLIP interactions: 35 interactions with chain A Hydrophobic interactions: A:Y.192, A:Y.192, A:P.317 Hydrogen bonds: A:L.16, A:A.17, A:F.35, A:E.36, A:E.36, A:R.37, A:R.37, A:R.38, A:A.55, A:A.55, A:R.110, A:R.110, A:L.134, A:L.134, A:D.310, A:D.310, A:G.322, A:M.323, A:N.324, A:N.324 Water bridges: A:G.15, A:G.18, A:R.37, A:R.37, A:G.166, A:A.170, A:D.310, A:D.310, A:A.311, A:A.326 pi-Cation interactions: A:R.110, A:R.110

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 6 residues within 4Å: Chain A: M.315, P.317, G.320, Q.321, G.322 Ligands: FAD.1 Ligand excluded by PLIP

1 x E1W: 6-chloranyl-5,7-dimethyl-4-(1~{H}-1,2,3,4-tetrazol-5-ylmethyl)-1,4-benzoxazin-3-one(Non-covalent)

E1W.3: 18 residues within 4Å: Chain A: A.55, R.83, Y.97, I.105, L.212, I.214, M.221, I.223, L.225, F.237, P.317, F.318, H.319, G.320, N.368, M.372, Y.403 Ligands: FAD.1 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.223 Hydrogen bonds: A:R.83, A:N.368, A:Y.403 pi-Stacking: A:Y.403

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, S. et al., A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites. Commun Biol (2019)

Release Date

2019-08-21

Peptides

Kynurenine 3-monooxygenase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Kynurenine 3-monooxygenase

Related Entries With Identical Sequence